Journal of Nursing ›› 2023, Vol. 30 ›› Issue (24): 33-37.doi: 10.16460/j.issn1008-9969.2023.24.033
Previous Articles Next Articles
HE Ya-ming1, WU Jian-wei1, SHE Ying-qi1, LIU Ning1,2
CLC Number:
[1] Thorpe KE, Zwarenstein M, Oxman AD, et al.A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers[J]. CMAJ, 2009,180(10):E47-57. DOI: 10.1503/cmaj.090523. [2] Loudon K, Treweek S, Sullivan F, et al.The PRECIS-2 tool: designing trials that are fit for purpose[J]. BMJ, 2015(350): h2147. DOI: 10.1136/ bmj. h2147. [3] 仇如霞,顾艳荭.范围综述报告规范(PRISMA-ScR)的解读[J].中国循证医学杂志, 2022, 22(6):722-730. DOI:10.7507/1672-2531.202203042. [4] Arksey H, O'Malley L. Scoping studies: towards a methodological framework[J]. Int J Soc Res Method, 2005, 8(1): 19-32. DOI: 10.1080/1364557032000119616. [5] Loudon K, Zwarenstein M, Sullivan FM, et al.The PRECIS-2 tool has good interrater reliability and modest discriminant validity[J]. J Clin Epidemiol, 2017(88):113-121. DOI: 10.1016 /j.jclinepi.2017.06.001. [6] 胡贵平,詹思延. PRECIS-2:基于研究目标的试验设计[J].中华流行病学杂志,2018,39(2):222-226. DOI:10.3760/cma.j.issn.0254-6450.2018.02.017. [7] Dal-Ré R, de Boer A, James SK. The design can limit PRECIS-2 retrospective assessment of the clinical trial explanatory/pragmatic features[J].J Clin Epidemiol, 2020(126): 193-201.DOI: 10.1016/j.jclinepi.2020.03.027. [8] Zwarenstein M, Thorpe K, Treweek S, et al.PRECIS-2 for retrospective assessment of RCTs in systematic reviews[J]. J Clin Epidemiol, 2020(126):202-206. DOI:10.1016/j.jclinepi.2020.06.023. [9] Nicholls SG, Zwarenstein M, Hey SP, et al.The importance of decision intent within descriptions of pragmatic trials[J]. J Clin Epidemiol, 2020(125):30-37. DOI:10.1016/j.jclinepi. 2020.04.030. [10] Lipman PD, Loudon K, Dluzak L, et al.Framing the conversation: use of PRECIS-2 ratings to advance understanding of pragmatic trial design domains[J]. Trials, 2017,18(1):532. DOI:10.1186/s13063-017-2267-y. [11] Kanzler KE, McGeary DD, McGeary C, et al. Conducting a pragmatic trial in integrated primary care: key decision points and considerations[J]. J Clin Psychol Med Settings, 2022,29(1):185-194. DOI:10.1007/s10880-021-09790-4. [12] Cruvinel E, Richter KP, Stoney C, et al.CHARTing a path to pragmatic tobacco treatment research[J].Am J Prev Med, 2016,51(4):630-636. DOI:10.1016/j.amepre.2016.05.025. [13] Elder WG, Munk N.Using the pragmatic-explanatory continuum indicator summar (PRECIS) model in clinical research: application to refine a practice-based research network(PBRN) study[J]. J Am Board Fam Med, 2014,27(6):846-854. DOI:10.3122/jabfm.2014.06.140042. [14] Sajobi TT, Li G, Awosoga O, et al.A comparison of Meta-analytic methods for synthesizing evidence from explanatory and pragmatic trials[J]. Syst Rev, 2018,7(1):19. DOI:10.1186/s13643-017-0668-3. [15] Fitzpatrick C, Gillies C, Seidu S, et al.Effect of pragmatic versus explanatory interventions on medication adherence in people with cardiometabolic conditions: a systematic review and Meta-analysis[J].BMJ Open,2020,10(7):e036575. DOI:10.1136/bmjopen-2019-036575. [16] Palmer JA, Mor V, Volandes AE, et al.A dynamic application of PRECIS-2 to evaluate implementation in a pragmatic, cluster randomized clinical trial in two nursing home systems[J]. Trials, 2018, 19(1):453. [17] Margolis KL, Crain AL, Green BB, et al. Comparison of explanatory and pragmatic design choices in a cluster-randomized hypertension trial: effects on enrollment, participant characteristics,adherence[J]. Trials, 2022,17;23(1):673. DOI:10.1186/s13063-022-06611-3. [18] Buchtele N, Schwameis M, Roth D, et al.Applicability of vasopressor trials in adult critical care: a prospective multicentre Meta-epidemiologic cohort study[J].Clin Epidemiol,2022(14):1087-1098. DOI:10.2147/CLEP.S372340. [19] Aves T, Allan KS, Lawson D, et al.The role of pragmatism in explaining heterogeneity in Meta-analyses of randomised trials: a protocol for a cross- sectional methodological review[J]. BMJ Open, 2017,7(9):e017887. DOI:10.1136/bmjopen-2017-017887. [20] Elliott N, Steel A, Leech B, et al.Design characteristics of comparative effectiveness trials for the relief of symptomatic dyspepsia: a systematic review[J]. Integr Med Res, 2021,10(2):100663. DOI:10.1016/j.imr.2020.10066.3. [21] Sajobi TT, Li G, Awosoga O, et al.A comparison of meta-analytic methods for synthesizing evidence from explanatory and pragmatic trials[J]. Syst Rev, 2018,7(1):19. DOI:10.1186/s13643-017-0668-3. [22] Dal-Ré R, Janiaud P, Ioannidis JPA.Real-world evidence: How pragmatic are randomized controlled trials labeled as pragmatic?[J]. BMC Med, 2018,16(1):49. DOI:10.1186/s 12916-018-1038-2. [23] 李锐臻,韩世范,程金莲,等. 国内护理学领域高影响因子期刊中临床RCT文献的质量评价[J].循证护理,2015,1(3):101-105. [24] An application of PRECIS-2 to evaluate trial design in a pilot cluster randomised controlled trial of a community-based smoking cessation intervention for women living in disadvantaged areas of Ireland[J].An application of PRECIS-2 to evaluate trial design in a pilot cluster randomised controlled trial of a community-based smoking cessation intervention for women living in disadvantaged areas of Ireland[J]. Pilot Feasibility Stud, 2022,8(1):19. DOI:10.1186/s40814-022-00969-6. |
[1] | CHEN En-lin, MO Feng-ling, ZHUANG Ze-ming, ZHANG Ming-zhe, ZHOU Jia-kun, HUANG Li-fang, JI Long-fei, ZHANG Li-fang. Assessment tools for unilateral spatial neglect after stroke: a scoping review [J]. Journal of Nursing, 2025, 32(3): 43-49. |
[2] | YANG Xiao-juan, MAO Xiao-rong, WANG Jing, JIANG Hua, LI Rong, FAN Yu, WEN Qing, LI Lin-zhang, CHEN Xiao-rong. Best evidence summary for early enteral nutrition management in adults with severe burns [J]. Journal of Nursing, 2025, 32(3): 56-61. |
[3] | WEI Li, ZHAO Xing-ying, LIU Jia, HE Yu-xuan, CHEN Xiao-mei, YANG Xue, XIAN Ji-shu, YANG Yan-ni. Care burden of family caregivers of severe inpatients in neurosurgery department and its influencing factors [J]. Journal of Nursing, 2025, 32(2): 1-6. |
[4] | YANG Bei, YE Hong-fang, ZHANG Ning, XIANG Lu-wei, LU Shi-yu. Current status of physical activity and its influencing factors in elderly patients with type 2 diabetes [J]. Journal of Nursing, 2025, 32(2): 7-12. |
[5] | CAO Min, ZHANG Pei-li, HOU Xiao-ya, GAO Chao-yue, GUO Lin-fang, LI Ying. Nutritional care experience of caregivers of colorectal cancer patients undergoing chemotherapy based on ABC-X model: a qualitative study [J]. Journal of Nursing, 2025, 32(2): 13-18. |
[6] | . [J]. Journal of Nursing, 2025, 32(2): 19-24. |
[7] | CHEN Yun, LU Yu-xuan, QI Yan-huan, MAO Jia-hui, ZHONG Yin-qin. Current status and trends of acupuncture and moxibustion in nursing of diabetic peripheral neuropathy: a bibliometric analysis [J]. Journal of Nursing, 2025, 32(2): 25-30. |
[8] | . [J]. Journal of Nursing, 2025, 32(2): 31-36. |
[9] | XIA Bi-yun, Chen Yu, WU Yan-yan, Hu Yan. Evidence-based practice to reduce incidence of radial artery occlusion in elderly patients after transradial coronary intervention [J]. Journal of Nursing, 2025, 32(2): 37-43. |
[10] | ZHU Tian-shun, ZHU Ke-ke, XUE Hui-yuan, JIAO Cong-cong, WEI Chang-hui, WANG He. Application of message framing theory in health management: a scoping review [J]. Journal of Nursing, 2025, 32(2): 44-49. |
[11] | LIU Shuo-yi, XIONG Li-juan, LI Ling, WANG Yu-mei, HE Jia, LI Xin, YUAN Shi-lei, GUO Xue-qin, WANG Yang-jing, ZHANG Hui-juan. Quality evaluation and content analysis of clinical practice guidelines for prevention and management of frailty in elderly hospitalized patients [J]. Journal of Nursing, 2025, 32(2): 50-55. |
[12] | . [J]. Journal of Nursing, 2025, 32(2): 56-62. |
[13] | . [J]. Journal of Nursing, 2025, 32(2): 63-69. |
[14] | NIU Qing-mei, YU Ying, ZHANG Qian, JIA Ya-tian, TIAN Yu. Construction of follow-up management evaluation index system for patients with lower extremity atherosclerotic occlusive disease based on “three-dimensional quality structure” model [J]. Journal of Nursing, 2025, 32(2): 70-73. |
[15] | YAN Ya-ling, LE Mei-ni, YAO Tao-qin, WANG Xue-lian, JIANG Jian-ling, XIN Yi. Construction of perioperative frailty management program for elderly patients with gastrointestinal tumors [J]. Journal of Nursing, 2025, 32(2): 74-78. |
|